Skip to main content

View full-text article in PMC

. 2007 Oct 15;52(1):77–84. doi: 10.1128/AAC.01229-07

TABLE 3.

MICs of time-kill study strains tested by broth macrodilution

Drug^j	MIC (μg/ml) for HMC strain:
Drug^j	1072^a^,^e^,ⁱ	63^a^,^d^,^h	1074^a^,^d^,ⁱ	5055^a^,^f^,^h	100^b^,^d^,^h	99^b^,^d^,^h	441^b^,^e^,^h	5048^b^,^f^,^h	1058^c^,^d^,ⁱ	228^c^,^e^,^h	3583^c^,^f^,^h	1541^c^,^g^,ⁱ
DC-159a	1	0.12	1	0.12	0.12	0.12	0.12	0.12	0.5	0.12	0.12	1
LEVO	16	1	16	1	1	1	0.5	1	8	1	1	16
MOXI	4	0.25	4	0.25	0.25	0.12	0.12	0.12	2	0.12	0.12	4
GATI	8	0.5	4	0.25	0.5	0.25	0.25	0.25	4	0.5	0.25	4
GEMI	0.5	0.06	0.25	0.03	0.06	0.06	0.016	0.03	0.12	0.06	0.03	0.5
Amox/Clav	0.016	0.016	0.03	0.03	0.25	0.25	0.12	0.5	2	2	2	4
Azithro	>64	0.016	0.03	2	0.03	0.016	>64	4	0.06	>64	2	>64

^a

Penicillin susceptible.

^b

Penicillin intermediate.

^c

Penicillin resistant.

^d

Macrolide susceptible.

^e

ermB positive.

^f

mefA positive.

^g

L4 mutations.

^h

Quinolone susceptible.

ⁱ

Quinolone resistant.

^j

LEVO, levofloxacin; MOXI, moxifloxacin; GATI, gatifloxacin; GEMI, gemifloxacin; Amox/Clav, amoxicillin-clavulanic acid; Azithro, azithromycin.